Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yu, Yung Luen ^a,b   Su, Kuo Jung ^a   Hsieh, Yi Hsien ^c   Lee, Hsiang Lin ^c,d   Chen, Tzy Yen ^c,d   Hsiao, Pei Ching ^c,d   Yang, Shun Fa ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; TRANSCRIPTION FACTOR EZH2;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISTANT METASTASIS; EZH2 GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOMOZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TUMOR VOLUME;

ADULT; AGED; ALCOHOL DRINKING; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POLYCOMB REPRESSIVE COMPLEX 2; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SMOKING;

EID: 84883802212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074870     Document Type: Article

References (28)

1. Bosch FX, Ribes J, Cleries R, Diaz M, (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211.
2. Department of Health RoC (2007) Health statistics: II. Vital statistics. Taipei: Department of Health.
3. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
4. Firpi RJ, Nelson DR (2006) Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program: 375-380.
5. Yano Y, Yamashita F, Kuwaki K, Fukumori K, Kato O, et al. (2006) Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver Int 26: 789-795.
6. Heyn H, Esteller M, (2013) EZH2: An Epigenetic Gatekeeper Promoting Lymphomagenesis. Cancer Cell 23: 563-565.
7. Dukers DF, van Galen JC, Giroth C, Jansen P, Sewalt RG, et al. (2004) Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am J Pathol 164: 873-881.
8. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100: 11606-11611.
9. Ren G, Baritaki S, Marathe H, Feng J, Park S, et al. (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72: 3091-3104.
10. Sauvageau M, Sauvageau G, (2010) Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7: 299-313.
11. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, et al. (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27: 7274-7284.
12. Shastry BS, (2002) SNP alleles in human disease and evolution. J Hum Genet 47: 561-566.
13. Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, et al. (2010) Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol 17: 1808-1815.
14. Weng CJ, Tsai CM, Chen YC, Hsieh YH, Lin CW, et al. (2010) Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol 17: 3394-3401.
15. Chen TY, Li YC, Liu YF, Tsai CM, Hsieh YH, et al. (2011) Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Ann Surg Oncol 18: 2348-2356.
16. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, et al. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536.
17. Crea F, Fornaro L, Paolicchi E, Masi G, Frumento P, et al. (2012) An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients. Ann Oncol. 23: 1207-1213.
18. Yoon KA, Gil HJ, Han J, Park J, Lee JS, (2010) Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer. J Thorac Oncol 5: 10-16.
19. Chen CJ, Yu MW, Liaw YF, (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12: S294-308.
20. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, et al. (2002) Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 98: 257-261.
21. Akkiz H, Bayram S, Bekar A, Ozdil B, Akgollu E, et al. (2009) G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 33: 261-264.
22. Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, et al. (2009) Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 47: 412-418.
23. Simon JA, Lange CA, (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647: 21-29.
24. Cardoso C, Mignon C, Hetet G, Grandchamps B, Fontes M, et al. (2000) The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders. Eur J Hum Genet 8: 174-180.
25. Shen Z, Chen L, Hao F, Wang G, Liu Y, (2010) Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding. J Cell Mol Med 14: 226-241.
26. Zhang W, Winder T, Ning Y, Pohl A, Yang D, et al. (2011) A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol 22: 104-109.
27. Lipkin SM, Chao EC, Moreno V, Rozek LS, Rennert H, et al. (2010) Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer Prev Res (Phila) 3: 597-603.
28. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, et al. (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296-1302.